☰
The biopharmaceutical company completes enrollment for Phase 1/2 clinical study of IDCT to treat patients with degenerative disc disease A clinical stage biopharmaceutical company, DiscGenics Inc., focused upon developing regenerative cell....
Pivotal, a full-service contract research organization (CRO), has reportedly acquired Akcelis BVBA, one of the leading players in patient recruitment, engagement, and retention, to offer its existing and future clients with patients’ ....
Neuraly has claimed that it has dosed the first patient of NLY01 in its Phase 2 study for Parkinson’s disease. Nature Medicine claimed in its study that NLYO1 tends to bind upregulated GLP-1R and blocks microglia’s pathological....
PAVmed Inc. has recently announced that Lucid Diagnostics has entered an agreement with UPenn (University of Pennsylvania) to perform clinical trial research for its EsoCheck device. Lucid Diagnostics is a subsidiary of PAVmed, a highly-dif....
Khiron Life Sciences Corp., a vertically integrated cannabis company, has recently obtained manufacturing quotas for high-THC medical cannabis from the TQG (Colombian Technical Quotas Group). The manufacturing quotas will authorize Khiron t....
Akumina, the leading digital workplace software platform, powering personalized digital employee experiences, recently announced plans to partner with BlueModus, a full-service technology agency. Together, BlueModus and Akumina p....
Altasciences Company, Inc., a clinical research organization specializing in end to end drug development, has reportedly announced the acquisition of U.S based pharmaceutical company, Alliance Contract Pharma. Following this acquisiti....
The free-streaming video service comes installed on smart televisions and is ad-supported Video service supported by ads has a large appeal to the younger consumers Comcast, the telecommunications conglomerate based in America....
Ascentage Pharma, a clinical-stage biotechnology firm developing innovative therapies for cancers, has reportedly received approval for its Phase Ib/II clinical trial from the CDE (Center of Drug Evaluation), China NMPA. The clinical trial....
Burgeoning numbers of coronavirus cases have encouraged researchers to develop a viable vaccine candidate. Clover Biopharmaceuticals, a Chinese clinical-stage biotechnology company developing transformative and novel biologic therapies, has....
